C3 Metals Inc (TSX-V:CCCM, OTC:CARCF) announced that it has obtained approvals to begin exploration drilling at its 100% owned Arthurs Seat project in Jamaica.
The junior minerals exploration company also said it has received new rock chip assays of up to 58.1 grams per tonne (g/t) gold, 16.5% copper, and 4,890 g/t silver -- the highest-grade sampled at the project to date.
Mountain Valley MD Holdings Inc (CSE:MVMD, OTCQB:MVMDF) said it has shifted focus to the commercialization strategy for those of its projects and technologies that it believes will best provide viable revenue streams for long-term company health and shareholder value.
In a business update, the company told investors it was working toward commercial advancement in three primary lines of business: novel innovations that improve the administration and efficacy of nutraceutical health and wellness products; agricultural plant signalling technology that organically drives increases in crop yields and supports and reduction of fertilizer usage; and the application of solubilized drugs to positively impact husbandry animal health.
Silver Range Resources Ltd (TSX-V:SNG, OTC:SLRRF) has announced results of recent airborne geophysical surveys, geological mapping and sampling at the Sand Springs Property in Nevada, which the company says has defined gold-copper skarn drill targets.
The precious metals prospect generator also said gold-copper skarn mineralization is found at surface, in underground workings and in drill holes within both the intrusion and surrounding Triassic-Jurassic limestone and metamorphosed clastic rocks.
Atlantic Lithium Limited (AIM:ALL, OTCQX:ALLIF, ASX:A11)’s promising assay results at its flagship Ewoyaa project in Ghana provide upside investment potential in the AIM-quoted company, according to analysts at house broker Liberum.
“Our analysis indicates Ewoyaa to be amongst the best in class in terms of returns, operating expense and capital expenditure,” said Liberum.
Copper Fox Metals Inc (TSX-V:CUU, OTCQX:CPFXF) has provided an update on its 100%-owned Eaglehead polymetallic porphyry copper project approximately 50 kilometers (km) east of Dease Lake in British Columbia.
"The 2022 program eliminated ‘legacy data issues’ with the project database, expanded the area of surface copper mineralization and revised the geology of the southwest portion of the Eaglehead Intrusive,” Elmer B. Stewart, president and CEO of Copper Fox said in a statement.
Endeavour Mining PLC (LSE:EDV, TSX:EDV, OTCQX:EDVMF) said it has boosted the measured and indicated gold resource at its Ity project in Côte D’Ivoire by 17% to 99mln tonnes at 1.62 grams per tonne gold for a total of 5.2mln ounces.
The company noted that drilling confirmed the continuity of the mineralised system which hosts seven deposits located near the processing plant. Mineralisation remains open at the West Flotouo, Daapleu, Bakatouo, Colline Sud and Walter deposits.
Atlantic Lithium Limited (AIM:ALL, OTCQX:ALLIF, ASX:A11) has released the results from a further 10,679 metres of drilling at the Ewoyaa lithium project in Ghana.
The company undertook diamond drilling and reverse circulation drilling at the Ewoyaa Main, Ewoyaa North-East, Kaampakrom and Grasscutter West deposits.
Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) said it has completed a new artificial intelligence (AI) model to deliver the first clinically meaningful analysis of its unique human challenge trial data in the first half of next year, with the aim of identifying novel influenza drug targets.
The infectious disease company said construction of the computational AI influenza disease model has been completed by CytoReason.
Marble Financial Inc. (CSE:MRBL, OTC:MRBLF) said it has closed the first tranche of its previously announced non-brokered private placement for an aggregate subscription amount of $1,371,051. The company said the first tranche closing was for an aggregate of 19,586,437 units at a price of 7 cents per unit and insider participation, consideration and related party disclosure was as stated in its previous November 8, 2022, news release.
Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) has announced the presentation of a poster at the 61st Annual Meeting of the American College of Neuropsychopharmacology, being held from December 4-7, 2022 in Phoenix, Arizona. The poster, titled 'An Open-Label Tolerability and Efficacy Study of ZYN002 (Cannabidiol) Administered as a Transdermal Gel to Children and Adolescents with 22q11.2 Deletion Syndrome (INSPIRE)', will be delivered in-person at Poster Session III, on December 7, 2022, from 5.30pm to 7.30pm MST at the JW Marriott Desert Ridge Resort and Spa, Phoenix, Arizona. The poster will also be available online beginning December 5, 2022 for the entirety of conference and a copy of the poster will be made available on the Zynerba corporate website following the presentation at www.zynerba.com/publications.
Nextech AR Solutions Corp. (CSE:NTAR, OTCQB:NEXCF) announced that its CEO Evan Gappelberg has purchased a total of 250,000 shares through open market buys with an average purchase price of US$0.70/ C$0.95 per share. The purchase increases Gappelberg’s ownership to 10,672,461 Nexctech AR common shares, representing 10.36% of the company's 103,012,103 common shares issued and outstanding. The Nextech AR CEO commented: “I continue to invest and buy Nextech shares because I’m extremely excited about our business prospects in 2023 and beyond, and I don’t believe that our current share price reflects the upside potential of our businesses. We have been building towards this moment in history where everything goes 3D for a long time, and I believe that Nextech is going to emerge as a KEY player in multiple 3D markets with lots of upside potential. He continued, “I'm very optimistic about our growth in 2023 and beyond. I’m investing today because I see many years of strong forward growth ahead for our businesses.”
ARway (CSE:ARWY) has announced that its CEO, Evan Gappelberg will present live at VirtualInvestorConferences.com on Thursday, December 1, 2022, at 3.30pm via the following link: Small Cap Growth Virtual Investor Conference | Virtual Investor Conferences. This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event.
Todos Medical Ltd. (OTCQB:TOMDF) announced that its majority-owned subsidiary 3CL Pharma was awarded oral and poster presentations at World Antiviral Congress 2022 in San Diego. The oral presentation is titled: “Showcase 6: Mechanism based designed 3CL inhibitors. From HRV to Covid19”, and will take place on 30th of November at 3:45pm PT. The poster presentation is titled: “NLC-V (Tollovir) as an Adjunctive Therapy in Hospitalized Patients Diagnosed with COVID-19: A Phase 2 Randomized, Double-Blind, Placebo-controlled Trial” in the Exhibition Hall at Loews Coronado Bay Resort.
Reunion Gold Corporation (TSX-V:RGD, OTCQB:RGDFF) has appointed incoming CEO Rick Howes to its board of directors. David Fennell, executive chairman commented: “On behalf of the Board of Reunion Gold, we welcome Rick as director.” Howes will be appointed president and CEO effective January 1, 2023. Reunion granted two million stock options to Howes. The options are exercisable at a price of $0.44, will vest in three installments starting on January 1, 2023, and have a term of five years. The options were granted pursuant to the company's incentive stock option plan and are subject to regulatory approval.
Fobi AI (TSX-V:FOBI, OTCQB:FOBIF). announced its first quarter 2023 financial statements have been filed on the company’s profile on SEDAR. Fobi will hold a Webinar with CEO Rob Anson and CFO Annie Chan to review the results and highlights from the interim quarter on Wednesday November 30th, 2022 at 9:00am PST/12 noon EST. Registration for the webinar is here. The company will answer pre-submitted questions at the conclusion of the prepared remarks. Investors are asked to submit their questions in advance to ir@fobi.ai. Further to news releases dated December 8, 2021 and January 13, 2022, the company is continuing its discussions with Passworks in efforts to complete the acquisition. Both parties see great value in the amalgamation and are working closely to finalize the transaction.
Xigem Technologies (CSE:XIGM, OTCQB:XIGMF) said it has entered into debt settlement agreements with three arm's length creditors whereby the company will settle outstanding payables totalling $361,229 through the issuance of 4,515,363 shares of the company at a price of $0.08 per share. The technology provider for the remote economy said this was save except for 353,125 shares, which will be issued pursuant to prospectus exemptions contained in section 2.24 of National Instrument 45-106 – Prospectus and Registration Exemptions.